Skip to main content

Table 1 Results of MTT and BrdU assay of substance 2250 compared with TRLT in three different cell lines

From: Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

 

AsPC-1

BxPC-3

Panc-1

TRLT

2250

TRLT

2250

TRLT

2250

MTT assay cell viability (%)

48.78 ± 2.8

21.00 ± 3.8

36.01 ± 7.3

26.24 ± 0.3

65.24 ± 1.5

24.4 ± 4.6

BrdU Assay cell proliferation (%)

8.5 ± 0.9

3.34 ± 0.2

6.66 ± 0.7

1.0 ± 0.2

16.32 ± 1.2

9.14 ± 0.3